Article Text
Editorial
Aducanumab for Alzheimer’s disease – too many unanswered questions
Statistics from Altmetric.com
Footnotes
Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).
Provenance and peer review Commissioned; externally peer reviewed.